| __timestamp | Agios Pharmaceuticals, Inc. | Ionis Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 100371000 | 241751000 |
| Thursday, January 1, 2015 | 141827000 | 322292000 |
| Friday, January 1, 2016 | 220163000 | 344320000 |
| Sunday, January 1, 2017 | 292681000 | 374644000 |
| Monday, January 1, 2018 | 1397000 | 1820000 |
| Tuesday, January 1, 2019 | 1317000 | 4000000 |
| Wednesday, January 1, 2020 | 2805000 | 12000000 |
| Friday, January 1, 2021 | 18777000 | 11000000 |
| Saturday, January 1, 2022 | 1704000 | 14000000 |
| Sunday, January 1, 2023 | 9504000 | 9133000 |
| Monday, January 1, 2024 | 4165000 |
In pursuit of knowledge
In the competitive world of biotechnology, cost efficiency can be a decisive factor for success. Ionis Pharmaceuticals, Inc. and Agios Pharmaceuticals, Inc. have been at the forefront of innovation, but how do they fare in managing their cost of revenue? From 2014 to 2023, Ionis consistently outpaced Agios, with an average cost of revenue nearly 70% higher. However, both companies saw significant fluctuations. Notably, in 2017, Ionis peaked with a cost of revenue of approximately $375 million, while Agios reached its zenith at $293 million. The subsequent years saw a dramatic reduction, with both companies reducing costs by over 90% by 2018. This trend highlights a strategic shift towards leaner operations. As the biotech landscape evolves, these insights into cost management could provide a competitive edge, offering lessons in financial prudence and operational efficiency.
Johnson & Johnson vs Agios Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Cost Insights: Breaking Down Sanofi and Ionis Pharmaceuticals, Inc.'s Expenses
Cost of Revenue Trends: Bristol-Myers Squibb Company vs Ionis Pharmaceuticals, Inc.
Cost of Revenue Trends: Neurocrine Biosciences, Inc. vs Ionis Pharmaceuticals, Inc.
Comparing Cost of Revenue Efficiency: Intra-Cellular Therapies, Inc. vs Ionis Pharmaceuticals, Inc.
Cost of Revenue Trends: Pharming Group N.V. vs Ionis Pharmaceuticals, Inc.
Comparing Cost of Revenue Efficiency: Ionis Pharmaceuticals, Inc. vs Alkermes plc
Cost of Revenue: Key Insights for Ionis Pharmaceuticals, Inc. and Travere Therapeutics, Inc.
Cost of Revenue: Key Insights for Ionis Pharmaceuticals, Inc. and Viridian Therapeutics, Inc.
Agios Pharmaceuticals, Inc. vs Iovance Biotherapeutics, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue: Key Insights for Agios Pharmaceuticals, Inc. and Taro Pharmaceutical Industries Ltd.